Gabapentin Safety in POTS Patients
Gabapentin is not a recommended or evidence-based treatment for POTS and should generally be avoided unless treating a specific comorbid condition (such as neuropathic pain), as it can worsen the core symptoms of POTS through its sedating and blood pressure-lowering effects.
Why Gabapentin is Problematic in POTS
The 2020 Canadian Cardiovascular Society guidelines 1 clearly outline the pharmacological management of POTS, listing the most common medications as: midodrine, propranolol, pyridostigmine, fludrocortisone, ivabradine, clonidine, and intermittent IV normal saline. Gabapentin is notably absent from this list.
Mechanism-Based Concerns
POTS treatment aims to:
- Improve central blood volume
- Enhance vasoconstriction
- Reduce sinus tachycardia
Gabapentin works against these goals through several mechanisms:
- Somnolence and dizziness are among the most common side effects (28% and 21% respectively in clinical trials) 2
- These effects can worsen orthostatic intolerance, the hallmark symptom of POTS
- The FDA label explicitly warns about increased risk of accidental injury and falls due to sleepiness and dizziness 2
- Gabapentin can cause peripheral edema (8% incidence) 2, which may complicate volume management in POTS
When Gabapentin Might Be Considered
There is one documented case where gabapentin was used successfully in a POTS patient—but critically, it was prescribed for pain management, not for POTS itself 3. This 17-year-old patient had an L1 vertebral hemangioma with radiating pain, and gabapentin addressed the neuropathic pain component.
Clinical Decision Algorithm
If considering gabapentin in a POTS patient:
Identify the specific indication - Is there neuropathic pain, seizures, or another FDA-approved indication separate from POTS?
Optimize POTS management first 1:
- Non-pharmacologic: 3L fluid/day, 10g sodium/day, compression garments, recumbent exercise
- First-line pharmacologic: Low-dose propranolol (10-20mg QID) or midodrine (2.5-15mg TID)
Monitor for worsening orthostatic symptoms if gabapentin is necessary:
- Increased dizziness upon standing
- Worsening fatigue (already common in POTS)
- Falls or near-syncope episodes
Start at the lowest effective dose and titrate slowly, as POTS patients may be more sensitive to sedating effects
Critical Pitfalls to Avoid
- Do not prescribe gabapentin as a POTS treatment - it has no evidence base for this indication and may worsen symptoms
- Avoid combining gabapentin with other sedating medications commonly used in POTS (like low-dose propranolol), as this compounds the risk of orthostatic symptoms 2
- Do not use gabapentin for "dysautonomia symptoms" without a specific diagnosis requiring it - this is a common prescribing error
Special Populations
In pediatric POTS patients (where gabapentin might be considered for comorbid conditions), be especially cautious as the FDA label warns about neuropsychiatric adverse reactions including emotional lability and hostility in children 3-12 years 2. POTS patients aged 13-25 already have high rates of these symptoms 1.
Bottom line: Gabapentin should only be used in POTS patients when treating a distinct comorbid condition with a clear indication, never as a POTS therapy itself, and only after optimizing evidence-based POTS treatments.